Health and Me

Rachel V Thomas

Ebola Cases Reach 1,155, Deaths Top 300 in Congo; WHO Warns of 70% Risk of Spread to South Sudan

The <span>Ebola outbreak</span> in the Democratic Republic of <span>Congo</span> continues to worsen, with cases rising to 1,155 and deaths climbing to 304, as per the latest government data.

The figures represent the total confirmed cases as of June 24, according to a situation report which documented 37 new cases and five new deaths in the previous 24 hours. Ituri, North Kivu and South Kivu remain the most affected provinces in Congo.

<a href="https://www.healthandme.com/health-news/france-confirms-first-ebola-case-congo-outbreak-grows-to-1094-cases-277-deaths-article-154743747" data-type="tilCustomLink">France </a> has become the first country outside Africa to report a case, involving a doctor who returned from Congo after delivering humanitarian services in Ituri.

Also read: <a href="https://www.healthandme.com/health-news/ebola-outbreak-the-unusual-symptoms-seen-in-patients-infected-with-bundibugyo-article-154757437" data-type="tilCustomLink">Ebola Outbreak: The Unique Symptoms Seen In Patients Infected With Bundibugyo</a>

The US is now providing doses of an experimental Ebola treatment developed by <span>Mapp Biopharmaceutical</span> for clinical trials in Congo.

The experimental therapy, known as MBP134, was developed by San Diego-based Mapp Biopharmaceutical. While the US had previously kept its stockpile for potential use in exposed American citizens, it is now making doses available to support clinical research in Congo. This is the first time Washington has publicly committed stockpiled supplies of the treatment for a broader international trial.

According to the World Health Organization, researchers will test MBP134 both on its own and alongside the antiviral drug <span>remdesivir</span>, marketed as Veklury. Remdesivir became widely known during the COVID-19 pandemic and is being evaluated to see whether it can improve outcomes when combined with the antibody treatment.

<h2>Ebola: Scientists Lack Access To Virus Samples </h2>

The ongoing outbreak is being driven by the rare <a href="https://www.healthandme.com/health-news/ebola-bundibugyo-strain-all-you-should-know-about-the-rare-virus-article-154341776" data-type="tilCustomLink">Bundibugyo strain</a>, for which no approved vaccine or treatment exists. However, scientists racing to develop vaccines and therapies are hampered by the lack of a viable sample of the virus.

“There’s nothing like having the authentic isolate,” said Thomas Geisbert, Professor of microbiology and immunology at the University of Texas Medical Branch in Galveston, who helped develop previous Ebola vaccines, Bloomberg reported.

“Despite so many cases, the global scientific community has not obtained a clinical sample to isolate the virus for the needed animal challenge studies,” added Jennifer Serwanga, head of immunology at the Uganda Virus Research Institute, the report said.

<h2>Ebola: WHO Warns Spread to South Sudan</h2>

Male Breast Cancer: The Warning Signs Most Men Don't Know

Further, as per a new WHO modelling study published in <em>The Lancet</em>, the growing Congo Ebola outbreak, which has already spread to Uganda, has a 70 per cent chance of reaching South Sudan soon.

The study combined epidemic modelling with spillover estimation to quantify regional risks associated with the 2026 Ituri outbreak using laboratory-confirmed case data from WHO Situation Reports (33 cases as of May 18, 2026, to 598 cases as of June 8, 2026), with projections extending 12 weeks from May 18 to Aug. 10, 2026. It also integrates operational preparedness considerations relevant for neighboring countries.

The report showed that even with the intensified response within DR Congo, uncertainty remains around reported case numbers due to the low rate of contact tracing.

“Sustained control nonetheless remains the primary determinant of regional risk: importation into Uganda is already established, and South Sudan must continue to reinforce infection prevention and control, rapid response capacity, and cross-border surveillance under International Health Regulations 2005,” said researchers from the WHO Regional Office for Africa, Nairobi, Kenya.

<ol><li><strong>Enhanced surveillance</strong> at formal and informal points of entry to detect suspected cases early and prevent silent transmission.</li><li><strong>Strengthen infection prevention and control (IPC)</strong> measures in front-line health facilities to reduce nosocomial transmission and protect health-care workers.</li><li><strong>Train, equip, and pre-position rapid response teams</strong> for immediate deployment.</li></ol>

Health Conditions A-Z

health

ebola-cases-reach-1155-deaths-top-300-in-congo-who-warns-of-70-risk-of-spread-to-south-sudan

ebola bundibugyo

ebola in congo

congo

Remdesivir

WHO Ebola warning

ebola outbreak

Mapp Biopharmaceutical

new-oral-glp-1-pill-delivers-major-weight-loss-in-just-36-weeks

New Oral GLP-1 Pill Delivers Major Weight Loss In Just 36 Weeks

after-covid-the-us-is-turning-to-the-same-organization-to-fight-ebola-in-dr-congo

After COVID, The US Is Turning To The Same Organization To Fight Ebola In DR Congo

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The Ebola outbreak in the Democratic Republic of Congo continues to worsen, with cases rising to 1,155 and deaths climbing to 304, as per the latest government data.The figures represent the total confirmed cases as of June 24, according to a situation report which documented 37 new cases and five new deaths in the previous 24 hours. Ituri, North Kivu and South Kivu remain the most affected provinces in Congo.France  has become the first country outside Africa to report a case, involving a doctor who returned from Congo after delivering humanitarian services in Ituri.Experimental treatmentsAlso read: Ebola Outbreak: The Unique Symptoms Seen In Patients Infected With BundibugyoThe US is now providing doses of an experimental Ebola treatment developed by Mapp Biopharmaceutical for clinical trials in Congo.The experimental therapy, known as MBP134, was developed by San Diego-based Mapp Biopharmaceutical. While the US had previously kept its stockpile for potential use in exposed American citizens, it is now making doses available to support clinical research in Congo. This is the first time Washington has publicly committed stockpiled supplies of the treatment for a broader international trial.According to the World Health Organization, researchers will test MBP134 both on its own and alongside the antiviral drug remdesivir, marketed as Veklury. Remdesivir became widely known during the COVID-19 pandemic and is being evaluated to see whether it can improve outcomes when combined with the antibody treatment.Ebola: Scientists Lack Access To Virus Samples The ongoing outbreak is being driven by the rare Bundibugyo strain, for which no approved vaccine or treatment exists. However, scientists racing to develop vaccines and therapies are hampered by the lack of a viable sample of the virus.“There’s nothing like having the authentic isolate,” said Thomas Geisbert, Professor of microbiology and immunology at the University of Texas Medical Branch in Galveston, who helped develop previous Ebola vaccines, Bloomberg reported.“Despite so many cases, the global scientific community has not obtained a clinical sample to isolate the virus for the needed animal challenge studies,” added Jennifer Serwanga, head of immunology at the Uganda Virus Research Institute, the report said.Ebola: WHO Warns Spread to South Sudan   Further, as per a new WHO modelling study published in The Lancet, the growing Congo Ebola outbreak, which has already spread to Uganda, has a 70 per cent chance of reaching South Sudan soon.The study combined epidemic modelling with spillover estimation to quantify regional risks associated with the 2026 Ituri outbreak using laboratory-confirmed case data from WHO Situation Reports (33 cases as of May 18, 2026, to 598 cases as of June 8, 2026), with projections extending 12 weeks from May 18 to Aug. 10, 2026. It also integrates operational preparedness considerations relevant for neighboring countries.The report showed that even with the intensified response within DR Congo, uncertainty remains around reported case numbers due to the low rate of contact tracing.“Sustained control nonetheless remains the primary determinant of regional risk: importation into Uganda is already established, and South Sudan must continue to reinforce infection prevention and control, rapid response capacity, and cross-border surveillance under International Health Regulations 2005,” said researchers from the WHO Regional Office for Africa, Nairobi, Kenya.The report called for:Enhanced surveillance at formal and informal points of entry to detect suspected cases early and prevent silent transmission.Strengthen infection prevention and control (IPC) measures in front-line health facilities to reduce nosocomial transmission and protect health-care workers.Train, equip, and pre-position rapid response teams for immediate deployment.

ebola cases reach 1,155, deaths top 300 in congo; who warns of 70% risk of spread to south sudan

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Ebola Cases Reach 1,155, Deaths Top 300 in Congo; WHO Warns of 70% Risk of Spread to South Sudan

After COVID, The US Is Turning To The Same Organization To Fight Ebola In DR Congo

Could Chemotherapy Soon Be Optional? AstraZeneca and Gilead Drugs Show Promise for Breast Cancer Patients

Ebola Outbreak: The Unique Symptoms Seen In Patients Infected With Bundibugyo

Health Conditions A-Z

Ebola Cases Reach 1,155, Deaths Top 300 in Congo; WHO Warns of 70% Risk of Spread to South Sudan

New Oral GLP-1 Pill Delivers Major Weight Loss In Just 36 Weeks

After COVID, The US Is Turning To The Same Organization To Fight Ebola In DR Congo